Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Visceral hypersensitivity in non-erosive reflux disease: neurogenic overwhelming in esophagus?

Chen CL.

Dig Dis Sci. 2013 Aug;58(8):2131-2. doi: 10.1007/s10620-013-2751-5. Epub 2013 Jun 29. No abstract available.

PMID:
23812863
2.

Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease.

Yoshida N, Kuroda M, Suzuki T, Kamada K, Uchiyama K, Handa O, Takagi T, Yoshikawa T, Kuramoto H.

Dig Dis Sci. 2013 Aug;58(8):2237-43. doi: 10.1007/s10620-012-2337-7. Epub 2012 Aug 17. Erratum in: Dig Dis Sci. 2013 Sep;58(9):2740-1.

PMID:
22899239
3.

Visceral hypersensitivity in non-erosive reflux disease.

Knowles CH, Aziz Q.

Gut. 2008 May;57(5):674-83. Epub 2007 Dec 13. Review. No abstract available.

PMID:
18079285
4.

[Non-erosive gastroesophageal reflux disease].

Blaszak A, Wojtuń S, Gil J, Wojtkowiak M, Dyrla P, Jałocha Ł.

Pol Merkur Lekarski. 2009 May;26(155):521-3. Review. Polish.

PMID:
19606715
5.

Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease.

Mancini V, Ribolsi M, Gentile M, de'Angelis G, Bizzarri B, Lindley KJ, Cucchiara S, Cicala M, Borrelli O.

Dig Liver Dis. 2012 Dec;44(12):981-7. doi: 10.1016/j.dld.2012.08.001. Epub 2012 Sep 10.

PMID:
22974565
6.

Is there a unifying role for visceral hypersensitivity and irritable bowel syndrome in non-erosive reflux disease?

Tack J.

Digestion. 2008;78 Suppl 1:42-5. doi: 10.1159/000151254. Epub 2008 Oct 2. Review.

PMID:
18832839
7.

Painful hypertrophic scarring and neuropeptides.

Parkhouse N, Crowe R, McGrouther DA, Burnstock G.

Lancet. 1992 Dec 5;340(8832):1410. No abstract available.

PMID:
1360111
8.

High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease.

Xu X, Li Z, Zou D, Yang M, Liu Z, Wang X.

Dig Dis Sci. 2013 Jan;58(1):53-60. doi: 10.1007/s10620-012-2308-z. Epub 2012 Sep 9.

PMID:
22961239
9.

Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.

Hartono JL, Qua CS, Goh KL.

Dig Dis Sci. 2011 Jan;56(1):90-6. doi: 10.1007/s10620-010-1275-5. Epub 2010 May 14.

PMID:
20467897
10.

Precise role of acid in non-erosive reflux disease.

Wang C, Hunt RH.

Digestion. 2008;78 Suppl 1:31-41. doi: 10.1159/000151253. Epub 2008 Oct 2. Review.

PMID:
18832838
11.

Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.

Fiedorek S, Tolia V, Gold BD, Huang B, Stolle J, Lee C, Gremse D.

J Pediatr Gastroenterol Nutr. 2005 Mar;40(3):319-27.

PMID:
15735486
12.

Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease.

Thoua NM, Khoo D, Kalantzis C, Emmanuel AV.

Aliment Pharmacol Ther. 2008 Mar 1;27(5):396-403. Epub 2007 Dec 7.

13.

Relevance of ineffective esophageal motility with erosive and nonerosive gastroesophageal reflux disease.

Foroutan M, Doust HM, Jodeiri B, Derakhshan F, Mohaghegh H, Mousapour H, Poursaadati S, Kiarudi MY, Zali M.

Indian J Gastroenterol. 2008 Mar-Apr;27(2):58-61.

PMID:
18695304
14.

Microalterations of esophagus in patients with non-erosive reflux disease: in-vivo diagnosis by confocal laser endomicroscopy and its relationship with gastroesophageal reflux.

Chu CL, Zhen YB, Lv GP, Li CQ, Li Z, Qi QQ, Gu XM, Yu T, Zhang TG, Zhou CJ, Rui-Ji, Li YQ.

Am J Gastroenterol. 2012 Jun;107(6):864-74. doi: 10.1038/ajg.2012.44. Epub 2012 Mar 13.

PMID:
22415199
15.

Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.

Martínek J, Benes M, Hucl T, Drastich P, Stirand P, Spicák J.

Scand J Gastroenterol. 2008;43(7):794-800. doi: 10.1080/00365520801908928.

PMID:
18584517
16.

Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease.

Daum C, Sweis R, Kaufman E, Fuellemann A, Anggiansah A, Fried M, Fox M.

Neurogastroenterol Motil. 2011 Jun;23(6):517-e200. doi: 10.1111/j.1365-2982.2011.01669.x. Epub 2011 Jan 28.

17.

[Prevalence of supraesophageal manifestations in patients with gastroesophageal erosive and non-erosive reflux disease].

Aguero GC, Lemme EM, Alvariz A, Carvalho BB, Schechter RB, Abrahão L Jr.

Arq Gastroenterol. 2007 Jan-Mar;44(1):39-43. Portuguese.

18.

Acid reflux is a poor predictor for severity of erosive reflux esophagitis.

Avidan B, Sonnenberg A, Schnell TG, Sontag SJ.

Dig Dis Sci. 2002 Nov;47(11):2565-73.

PMID:
12452396
19.

[Higher prevalence of obesity in erosive gastroesophageal reflux disease].

Biccas BN, Lemme EM, Abrahão LJ Jr, Aguero GC, Alvariz A, Schechter RB.

Arq Gastroenterol. 2009 Jan-Mar;46(1):15-9. Portuguese.

20.

[Cytokine expression in GERD].

Yoshida N.

Nihon Rinsho. 2007 May;65(5):813-21. Review. Japanese.

PMID:
17511218

Supplemental Content

Support Center